Correction on USP25 Variants and Genetic Epilepsy
Researchers focused on understanding the role of a specific gene called USP25 in genetic generalized epilepsy.
-
-
Understanding Cognitive Challenges in Children with Epilepsy Surgery
Researchers studied how cognitive function is affected in children with epilepsy, particularly those who might need surgery.
-
Secure Video Sharing Tool Helps Diagnose Pediatric Epilepsy
Researchers conducted a study to explore the use of a secure digital tool for sharing videos of suspected seizures in children.
-
First-Line Seizure Medications Work Similarly for Children
Researchers conducted a study to understand how effective first-line antiseizure medications (ASMs) are for children newly diagnosed with epilepsy.
-
Pregnancy Outcomes for Individuals With Epilepsy
Researchers conducted a study to examine the experiences and outcomes of pregnant individuals with epilepsy.
-
Phenytoin’s Impact on Driving Safety and Performance
Researchers conducted a study to understand how the antiepileptic drug phenytoin affects driving performance and cognitive abilities.
-
Using Anticonvulsants to Improve Outcomes After Cardiac Arrest
Researchers investigated the effects of using preventive anticonvulsant medications in patients who experienced cardiac arrest and were treated with mild hypothermia.
-
Comorbidities | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics | Status Epilepticus
Levetiracetam as First Choice Treatment for Non-Convulsive Status Epilepticus
Researchers investigated the use of intravenous (i/v) levetiracetam (LEV) as a first-line treatment for patients experiencing non-convulsive status epilepticus (NCSE), a serious condition where seizures occur without noticeable convulsions.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics | Status Epilepticus
Comparing Two Drugs for Children With Severe Seizures
Researchers conducted a study to compare the effectiveness and safety of two medications, levetiracetam and sodium valproate, in treating children aged 1 to 16 years who were experiencing refractory generalized convulsive status epilepticus.
